Related Experiment Video
Updated: May 28, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
[Venous thrombembolism in tumour patients]
I Pabinger1, B Alt-Epping, F Demarmels Biasutti
1Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische Abteilung für Hämatologie und Hämostaseologie, Wien. ingrid.pabinger@meduniwien.ac.at
Venous thromboembolism (VTE) is a common cancer complication. New guidelines offer recommendations for VTE diagnostics, prophylaxis, and treatment in cancer patients, balancing efficacy with bleeding risks.
Area of Science:
- Oncology
- Hematology
- Thrombosis
Context:
- Venous thromboembolism (VTE) is a frequent complication in cancer patients.
- Current VTE prophylaxis and therapy require balancing major bleeding risks and patient burden.
- Recent guidelines address VTE management in oncology.
Purpose:
- To provide updated recommendations for VTE diagnostics in cancer patients.
- To outline strategies for individualizing VTE prophylaxis and treatment in cancer.
- To balance the benefits of VTE management against bleeding risks.
Summary:
- Guidelines from German medical societies offer recommendations for VTE in cancer patients.
- These guidelines cover diagnostics, individual prophylaxis, and treatment strategies.
- The recommendations aim to optimize VTE care while minimizing bleeding complications.
Impact:
- Improved VTE management for cancer patients.
- Reduced bleeding complications associated with VTE treatment.
- Standardized approach to VTE care in German-speaking oncology and hematology settings.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
